Wednesday, July 28, 2021
Home Tags PP XPhyto Therapeutics Corp

PP XPhyto Therapeutics Corp Related News

XPhyto

XPhyto expands infection prevention offering with new acquisition

Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions. The move is the latest development in XPhyto’s...
Precise Rapid Testing: the key to reopening Germany’s economy

Precise Rapid Testing: the key to reopening Germany’s economy

Following the revelation that antigen tests are increasingly inaccurate, XPhyto Therapeutics have the solution, a point-of-care PCR test that yields results in only 25...
mescaline

XPhyto: Is mescaline the next big mood-modifying medicine?

Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Xphyto expects approval for 25-minute COVID-19 RT-PCR test

Xphyto expects approval for 25-minute COVID-19 RT-PCR test

XPhyto Therapeutics Corp. and its exclusive German diagnostics development partner, 3a-diagnostics GmbH, are expecting approval of the commercial in vitro rapid point-of-care COVID-19 RT-PCR...
XPhyto Therapeutics Corp expanding the realms of cannabis cultivation

XPhyto Therapeutics Corp expanding the realms of cannabis cultivation

Meet Bunker, XPhyto’s wholly owned German subsidiary, who now has a cannabis cultivation and extraction licence for scientific research. XPhyto Therapeutics Corp. is pleased to...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest